Plausible mechanisms were proposed that obesity increases uterine cancer risk by augmenting aromatase activity, which converts androgen to estrogen to promote endometrial proliferation [30]. Here, CYP19A1 is linked to obesity due to melanocortin 4 receptor deficiency.